Trials / Completed
CompletedNCT06041438
A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood
Effect of Itraconazole on the Pharmacokinetics of a Single Oral Dose of BI 1584862 in Healthy Male Subjects (an Open-label, Two-period, Fixed-sequence Design Study)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this trial is to investigate the effect on the exposure of BI 1584862 in plasma when given as single dose together with multiple doses of itraconazole (Test, T) as compared to BI 1584862 when given alone as oral single dose (Reference, R).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 1584862 | BI 1584862 |
| DRUG | itraconazole | itraconazole |
Timeline
- Start date
- 2023-09-29
- Primary completion
- 2023-11-10
- Completion
- 2023-11-10
- First posted
- 2023-09-18
- Last updated
- 2023-11-28
Locations
1 site across 1 country: Germany
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06041438. Inclusion in this directory is not an endorsement.